2026 Akseli Hemminki: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	85	3095	2849	20	19	461	32954
Medicine	85	14444	13601	165	152	489	33209

Overview

Akseli Hemminki is affiliated with the University of Helsinki in Finland. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on oncology-related studies.

The main subfields of Hemminki's work include:

Oncology
Genetics
Biotechnology
Immunology
Pulmonary and Respiratory Medicine

The research topics covered by Hemminki emphasize various aspects of cancer and immunotherapy, notably:

Virus-based gene therapy research
CAR-T cell therapy research
Cancer Research and Treatments
Immunotherapy and Immune Responses
Global Cancer Incidence and Screening
Viral Infectious Diseases and Gene Expression in Insects
Cancer Genomics and Diagnostics

Recent publications by Hemminki or related to their research domain include the following papers:

"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death," 2020, Journal for ImmunoTherapy of Cancer
"Oncolytic viruses for cancer immunotherapy," 2020, Journal of Hematology & Oncology
"Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity," 2020, Journal for ImmunoTherapy of Cancer
"Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors," 2020, Molecular Therapy - Oncolytics
"Familial Risks and Proportions Describing Population Landscape of Familial Cancer," 2021, Cancers

Frequent coauthors who have collaborated extensively with Hemminki are:

João M. Santos
Víctor Cervera-Carrascón
Kari Hemminki
Asta Försti
Dafne C.A. Quixabeira

Publications associated with Hemminki's work have appeared predominantly in the following venues:

Cancers
Regular and Young Investigator Award Abstracts
Cancer Medicine
Clinical Epidemiology
International Journal of Cancer

Best Publications

A serine/threonine kinase gene defective in Peutz–Jeghers syndrome

A Hemminki;D Markie;I Tomlinson;E Avizienyte

2069
Citations
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.

Heikki Joensuu;Pirkko-Liisa Kellokumpu-Lehtinen;Petri Bono;Tuomo Alanko

1841
Citations
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Tyler J Curiel;Shuang Wei;Haidong Dong;Xavier Alvarez

1543
Citations
Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease

L A Aaltonen;R Salovaara;P Kristo;F Canzian

1398
Citations
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian

1009
Citations
Patterns of metastasis in colon and rectal cancer

Matias Riihimäki;Matias Riihimäki;Akseli Hemminki;Jan Sundquist;Kari Hemminki;Kari Hemminki

903
Citations
Consensus guidelines for the detection of immunogenic cell death

Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

866
Citations
Metastatic sites and survival in lung cancer

Matias Riihimäki;Matias Riihimäki;A Hemminki;Mahdi Fallah;Hauke Thomsen

772
Citations
Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis

A Hemminki;I Tomlinson;D Markie;H Järvinen

590
Citations
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14

Hongjie Wang;Hongjie Wang;Zong Yi Li;Ying Liu;Jonas Persson

470
Citations
Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.

Akseli Hemminki;Akseli Hemminki;Jukka–Pekka Mecklin;Heikki Järvinen;Lauri A. Aaltonen

468
Citations
Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.

Hemminki A;Peltomäki P;Mecklin Jp;Järvinen H

440
Citations
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

416
Citations
Metastatic spread in patients with gastric cancer.

Matias Riihimäki;Akseli Hemminki;Kristina Sundquist;Jan Sundquist

378
Citations
Targeting Adenovirus to the Serotype 3 Receptor Increases Gene Transfer Efficiency to Ovarian Cancer Cells

Anna Kanerva;Galina V. Mikheeva;Victor Krasnykh;Candace J. Coolidge

361
Citations
Mitochondrial myopathy induces a starvation-like response

Henna Tyynismaa;Christopher J. Carroll;Nuno Raimundo;Sofia Tuulikki Ahola-Erkkilä

332
Citations
The epidemiology of metastases in neuroendocrine tumors.

Matias Riihimäki;Akseli Hemminki;Kristina Sundquist;Jan Sundquist

332
Citations
Semiautomated Assessment of Loss of Heterozygosity and Replication Error in Tumors

F. Canzian;R. Salovaara;A. Hemminki;P. Kristo

323
Citations
Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.

Anniina Koski;Anniina Koski;Lotta Kangasniemi;Sophie Escutenaire;Sophie Escutenaire;Sari Pesonen;Sari Pesonen

270
Citations
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients.

Sari Pesonen;Iulia Diaconu;Lotta Kangasniemi;Tuuli Ranki

156
Citations